Area of research
Molecular Biology · Computational Theory and Mathematics
Research interest
Research interests include Computational Drug Discovery Methods, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, and Organophosphorus compounds synthesis.
Table S3 and S4 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Table S9 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Table S3 and S4 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Supplementary Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Data from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Data from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Supplementary Figures S1-S7 from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Table S10 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Table S1 and S2 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Supplementary Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Table S5, S6 and S7 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Supplementary Figures S1-S7 from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Table S10 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Table S1 and S2 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
Table S5, S6 and S7 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
Table S9 from Zebrafish: Speeding Up the Cancer Drug Discovery Process
CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage.
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with <i>In Vivo</i> Efficacy in Multiple Myeloma.
Dual Targeting of G9a and DNA Methyltransferase‐1 for the Treatment of Experimental Cholangiocarcinoma
Towards the understanding of the activity of G9a inhibitors: an activity landscape and molecular modeling approach.
2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors: <i>In Vivo</i> Evaluation in a Murine Model of Acute Pancreatitis.
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression.
Dual Targeting of Histone Methyltransferase G9a and DNA-Methyltransferase 1 for the Treatment of Experimental Hepatocellular Carcinoma.
Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
Targeting CB<sub>1</sub> and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson's Disease.
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors.